Insights Hub

Explore the QII Healthcare AI Quality Framework

Executive Knowledge & Research

QII Insights

Independent research and executive interpretation for leaders responsible for healthcare AI quality, Medicare Advantage performance, governance, and measurable value.

Available now

Current QII Research

Public Framework

QII Healthcare AI Quality Framework™

A six-domain capability model connecting strategy, data, intelligence, intervention, governance, and outcomes.

View the Framework
Research Briefing · PUB-RB-001

The State of AI in Medicare Advantage Quality

An evidence-based examination of what AI currently supports in Medicare Advantage quality—and where evidence remains limited.

Read the Briefing

Publication pipeline

Planned Publications

The dates below reflect QII’s controlled publication pipeline. Release timing may change when evidence governance, editorial review, design, or final release QA requires additional work.

September 29, 2026

From Prediction to Intervention

Research Briefing #2 · PUB-RB-002 · Complete/Frozen — Scheduled

Why healthcare quality AI must estimate who is most likely to benefit, not only who is at risk.

October 6, 2026

AI and Medication Adherence

Evidence Review · Planned
October 13, 2026

From Prediction to Intervention: Executive Interpretation

Executive Article · Scheduled
October 20, 2026

Measuring Healthcare AI Beyond Accuracy

Research Briefing #3 · Planned
November 3, 2026

AI-Guided Care-Gap Closure

Evidence Review · Planned
November 10, 2026

The QII Healthcare AI Quality Maturity Model

Research Briefing #4 · Planned
November 24, 2026

The Economics of Healthcare AI

Research Briefing #5 · Planned
December 15, 2026

Healthcare AI Quality 2027

Flagship White Paper · Planned / Evidence Accumulation
QII publication control: Planned titles and dates are forward-looking editorial targets. QII publishes only after evidence review, claim verification, editorial approval, and release QA are complete.

Bring an Executive Question to QII

Request a confidential briefing or discuss an independent research and advisory need.

Contact QII